Grufity logoGrufity logo

NUS

41.35USD-0.27(-0.65%)Market Closed

NU Skin Enterprises Inc

Market Summary

USD41.35-0.27Market Closed
-0.65%

NUS Alerts

NUS Stock Price

RSI Chart

Valuation

Market Cap

2.0B

Price/Earnings

17.83

Price/Sales

0.82

Price/Cashflow

10.44

MarketCap/EBT

11.23

Price/Sales

Profitability

EBT Margin

7.27%

Return on Equity

12.06%

Return on Assets

5.97%

Fundamentals

Revenue

Revenue (TTM)

2.5B

Revenue Y/Y

-20.37%

Revenue Q/Q

-7.32%

Earnings

Earnings (TTM)

113.5M

Earnings Y/Y

-42.3%

Earnings Q/Q

-11.57%

Price Action

52 Week Range

29.9656.30
(Low)(High)

Last 7 days

-2.6%

Last 30 days

21.1%

Last 90 days

4.6%

Trailing 12 Months

-8.7%

Financial Health

Current Ratio

2.3

Debt/Equity

0.4

Debt/Cashflow

0.51

Investor Care

Dividend Yield

0.79%

Shares Dilution (1Y)

0.49%

Diluted EPS (TTM)

2.23

Peers (Alternatives to NU Skin Enterprises)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
320.4B
80.5B
11.04% 0.55%
21.99
3.98
4.31% 3.03%
72.2B
17.3B
12.60% -30.28%
29.98
4.07
1.35% -16.24%
62.3B
17.7B
5.49% 0.63%
32.33
3.51
2.30% -27.65%
42.0B
20.2B
11.01% 2.35%
23.52
2.08
5.04% -10.62%
18.2B
7.0B
4.45% -10.18%
39.49
2.57
-2.63% -7.32%
MID-CAP
5.6B
5.3B
14.72% -18.88%
21.76
1.06
9.13% 182.41%
3.3B
1.4B
0.04% 13.88%
57.07
2.5
9.98% 198.19%
2.3B
5.3B
-19.58% -66.34%
6.82
0.42
-9.40% -36.81%
2.1B
2.2B
6.16% -4.08%
19.02
0.95
4.04% -15.73%
2.0B
2.5B
21.08% -8.68%
17.83
0.82
-12.44% -52.04%
SMALL-CAP
1.3B
1.7B
9.23% -40.89%
8.24
0.78
30.75% 4.27%
978.6M
39.4M
-45.31% -8.41%
-20.8
18.67
-35.76% -1232.97%
173.8M
447.3M
1.30% -50.57%
10.09
0.39
8.21% -28.15%
49.5M
204.9M
1.32% -40.12%
15.85
0.24
-6.25% -96.99%
41.3M
52.7M
-0.22% -33.27%
52.94
0.75
-12.83% -77.69%

Financials for NU Skin Enterprises

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Revenue-5.5%2,4802,6242,6962,7702,833
Gross Profit-6.1%1,8381,9572,0202,0742,112
Operating Expenses-4.9%1,6481,7341,7861,7721,801
  S&GA Expenses-5.9%9791,0401,0681,0961,121
  R&D Expenses-27
Earnings Before Taxes-17.6%180219232305312
Net Income-18.1%113139147230237
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Assets0.5%1,9011,8921,9061,9742,050
  Current Assets4.0%883849873891962
    Cash Equivalents20.4%364302340282355
  Inventory-7.2%354382400415391
  Net PPE-1.3%443449454464474
  Goodwill0%206206206216216
Liabilities0.2%9609589941,0381,132
  Current Liabilities-22.3%384494530541616
  Long Term Debt-378----
    LT Debt, Current-63.6%40110108110153
    LT Debt, Non Current49.5%387259269279288
Shareholder's Equity0.7%941934913936918
  Retained Earnings0.8%1,9461,9311,9121,9401,909
  Additional Paid-In Capital1.2%606599602591587
Shares Outstanding0.8%50505050-
Float-2,800----
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Cashflow From Operations15.4%194168142127215
  Share Based Compensation-22.2%1621232529
Cashflow From Investing22.6%-61.97-80.06-88.73-102.64-106.17
Cashflow From Financing13.9%-103.54-120.31-104.70-110.62-141.40
  Dividend Payments0.5%7776767677
  Buy Backs0%4040808797

Risks

What is the probability of a big loss on NUS?

72.7%


Probability that NU Skin Enterprises stock will be more than 20% underwater in next one year

64.2%


Probability that NU Skin Enterprises stock will be more than 30% underwater in next one year.

38.1%


Probability that NU Skin Enterprises stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NUS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if NU Skin Enterprises was unfortunately bought at previous high price.

Returns

Cumulative Returns on NUS

1.8%


10-Year Cumulative Returns

4.3%


7-Year Cumulative Returns

-6.4%


5-Year Cumulative Returns

5.3%


3-Year Cumulative Returns

What are the long-term rolling returns for NUS?

FIve years rolling returns for NU Skin Enterprises.

Which funds bought or sold NUS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Eagle Bay Advisors LLC
REDUCED
-29.79
-16,030
19,000
0.01%
2022-11-23
Aurora Investment Counsel
SOLD OFF
-100
-2,323,000
-
-%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
339,000
339,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-1.29
-668,000
2,122,000
-%
2022-11-21
Parallax Volatility Advisers, L.P.
NEW
-
-
-
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-158,000
-
-%
2022-11-16
Retirement Systems of Alabama
REDUCED
-0.28
-663,000
2,201,000
0.01%
2022-11-15
ALGERT GLOBAL LLC
SOLD OFF
-100
-553,000
-
-%
2022-11-15
BURNEY CO/
SOLD OFF
-100
-1,731,000
-
-%
2022-11-15
JANE STREET GROUP, LLC
SOLD OFF
-100
-507,000
-
-%

1–10 of 44

Latest Funds Activity

Are funds buying NUS calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own NUS

NU Skin Enterprises News

Simply Wall St

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?.2 days ago

NUS Fair Value

Recent SEC filings of NU Skin Enterprises

View All Filings
Date Filed Form Type Document
Nov 28, 2022
4
Insider Trading
Nov 22, 2022
4
Insider Trading
Nov 03, 2022
10-Q
Quarterly Report
Nov 02, 2022
8-K
Current Report
Oct 24, 2022
4
Insider Trading
Sep 22, 2022
4
Insider Trading
Sep 08, 2022
4
Insider Trading
Sep 08, 2022
4
Insider Trading
Aug 25, 2022
4
Insider Trading

Latest Insider Trading transactions for NUS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-25
NAPIERSKI RYAN S
ACQUIRED
849,150
33.966
25,000
President and CEO
2022-11-25
NAPIERSKI RYAN S
SOLD
-961,250
38.45
-25,000
President and CEO
2022-11-22
LIPMAN ANDREW D
SOLD
-38,160
38.16
-1,000
-
2022-10-21
LIPMAN ANDREW D
SOLD
-35,920
35.92
-1,000
-
2022-09-22
LIPMAN ANDREW D
SOLD
-36,670
36.67
-1,000
-
2022-09-07
Thomas James D
SOLD
-62,782.4
39.19
-1,602
Chief Accounting Officer
2022-09-07
WOODBURY EDWINA D
ACQUIRED
593.1
39.54
15
-
2022-08-25
NAPIERSKI RYAN S
ACQUIRED
856,100
34.244
25,000
President and CEO
2022-08-25
NAPIERSKI RYAN S
SOLD
-1,074,860
42.9946
-25,000
President and CEO
2022-08-22
LIPMAN ANDREW D
SOLD
-45,010
45.01
-1,000
-

1–10 of 50

NUS Income Statement

2022-09-30
Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Consolidated Statements of Income [Abstract]    
Revenue$ 537,805$ 641,152$ 1,703,319$ 2,022,233
Cost of sales173,500158,907483,099501,448
Gross profit364,305482,2451,220,2201,520,785
Operating expenses:    
Selling expenses216,478260,333678,603816,887
General and administrative expenses137,987156,528428,105490,225
Restructuring and impairment expenses30,124030,1240
Total operating expenses384,589416,8611,136,8321,307,112
Operating income (loss)(20,284)65,38483,388213,673
Other income (expense), net(8,680)2,781(18,773)351
Income (loss) before provision for income taxes(28,964)68,16564,615214,024
Provision (benefit) for income taxes(3,574)18,43617,05257,527
Net income (loss)$ (25,390)$ 49,729$ 47,563$ 156,497
Net income (loss) per share (Note 6):    
Basic (in dollars per share)$ (0.51)$ 0.99$ 0.95$ 3.11
Diluted (in dollars per share)$ (0.51)$ 0.97$ 0.94$ 3.03
Weighted-average common shares outstanding:    
Basic (in shares)50,19950,09850,18750,304
Diluted (in shares)50,19951,26050,82251,629

NUS Balance Sheet

2022-09-30
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 294,136$ 339,593
Current investments13,86815,221
Accounts receivable, net47,99141,299
Inventories, net327,481399,931
Prepaid expenses and other94,36676,906
Total current assets777,842872,950
Property and equipment, net433,367453,674
Operating lease right-of-use assets105,103120,973
Goodwill206,432206,432
Other intangible assets, net68,74376,991
Other assets171,685175,460
Total assets1,763,1721,906,480
Current liabilities:  
Accounts payable41,62049,993
Accrued expenses281,418372,201
Current portion of long-term debt42,500107,500
Total current liabilities365,538529,694
Operating lease liabilities78,05388,759
Long-term debt382,323268,781
Other liabilities95,324106,474
Total liabilities921,238993,708
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:  
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued9191
Additional paid-in capital609,886601,703
Treasury stock, at cost - 40.9 million and 40.7 million shares(1,559,967)(1,526,860)
Accumulated other comprehensive loss(109,385)(73,896)
Retained earnings1,901,3091,911,734
Total stockholders' equity841,934912,772
Total liabilities and stockholders' equity$ 1,763,172$ 1,906,480